This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.70% per year. These returns cover a period from January 1, 1988 through April 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
saas: Archive
Hinge Health Inc. (HNGE)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
HNGEPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Can FIG Accelerate Its Retention Rate With Seat Expansion?
by Zacks Equity Research
Figma's 139% retention rate is fueled by enterprise seat expansion and wider adoption, but slower hiring and spending cuts can test growth.
FIGNegative Net Change ADBENegative Net Change TEAMNegative Net Change
saas
Salesforce's Agentforce ARR Tops $1B: Can It Fuel More Growth for CRM?
by Anirudha Bhagat
CRM's Agentforce ARR jumps 205% year over year and reaches $1.2B in Q1'27, showing surging automation demand and growth momentum.
MSFTNegative Net Change CRMNegative Net Change ORCLNegative Net Change
artificial-intelligence computers internet saas tech-stocks
Can Mastercard's TIPS Pilot Improve Cross-Border Payment Efficiency?
by Rajshree Sipani
MA tests instant euro-krona payments on TIPS, validating atomic settlement and end-to-end cross-border processing.
MAPositive Net Change VPositive Net Change AXPNegative Net Change
business-services fin-tech finance payments saas
Figma Stock Plunges 27.4% YTD: Should Investors Buy, Sell or Hold?
by Subham Roy
FIG faces rising AI costs, fierce competition and seat-growth risks despite strong retention and revenue growth. Is the stock's premium justified?
MSFTNegative Net Change FIGNegative Net Change ADBENegative Net Change TEAMNegative Net Change
saas
5 Software Stocks That Could Keep Soaring as AI Disruption Fears Fade
by Shaun Pruitt
Software stocks soared on Monday as investors grow increasingly confident that artificial intelligence will serve as a powerful growth catalyst rather than an existential threat to the industry's business models.
INTUNegative Net Change SNOWNegative Net Change TEAMNegative Net Change DOCUNegative Net Change DDOGNegative Net Change
artificial-intelligence earnings investing saas software tech-stocks
Block (XYZ) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
XYZNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Autolus Therapeutics PLC Sponsored ADR (AUTL) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
AUTLNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
IBM Expands Lightedge Tie-Up for Improved Cloud Offering: Worth a Buy?
by Supriyo Bose
IBM deepens Lightedge tie-up, integrating PowerVS into Lightedge???s hybrid cloud offering to simplify IBM Power management across providers.
AMZNNegative Net Change MSFTNegative Net Change IBMNegative Net Change
artificial-intelligence cloud-computing communications computers iot saas software tech-stocks
After Golden Cross, AbCellera Biologics Inc. (ABCL)'s Technical Outlook is Bright
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
ABCLNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines